Both IMU and IMM have positive early phase 2 data at the moment. the difference is the size of the studies. Immutep studies are potential landmark studies for registration. the size of IMU studies are aimed at proving concepts.
Ann: Ulcerative Colitis Phase II Study of GSK2831781 Discontinued, page-10
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $443.0M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $265.2K | 870.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 129847 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 174689 | 16 |
View Market Depth
| Last trade - 11.41am 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |